When, where, and how to target vascular inflammation in the post-CANTOS era?
Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)
Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease: Why, How, and When
MINOCA: a heterogenous group of conditions associated with myocardial damage
Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?
Endocardium Minimally Contributes to Coronary Endothelium in the Embryonic Ventricular Free Walls
2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.